PAHC (Phibro Animal Health) Owner Earnings per Share (TTM): 0.71 (As of Mar. 2026) — 98% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PAHC Phibro Animal Health Corp PAHC
75 GF Score
Price $34.26
GF Value $29.54
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Phibro Animal Health Owner Earnings per Share (TTM)?

Phibro Animal Health PAHC -3.41% 75 Owner Earnings per Share (TTM) is 0.71 as of Mar. 2026, which is 98% below its 10-year median of 31.59. GuruFocus rates PAHC with a GF Scoreâ„¢ of 75/100 and a GF Valueâ„¢ of $29.54 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 470 Drug Manufacturers companies, Phibro Animal Health ranks worse than 75.74% on this metric.

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Phibro Animal Health's Owner Earnings per Share (TTM) ended in Mar. 2026 was $0.71. It's Price-to-Owner-Earnings ratio for today is 48.25.


The historical rank and industry rank for Phibro Animal Health's Owner Earnings per Share (TTM) or its related term are showing as below:

PAHC' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 12.54   Med: 31.59   Max: 436.78
Current: 48.13


During the past 13 years, the highest Price-to-Owner-Earnings ratio of Phibro Animal Health was 436.78. The lowest was 12.54. And the median was 31.59.


PAHC's Price-to-Owner-Earnings is ranked worse than
75.74% of 470 companies
in the Drug Manufacturers industry
Industry Median: 23.33 vs PAHC: 48.13

Phibro Animal Health's Earnings per Share (Diluted) for the three months ended in Mar. 2026 was $0.59. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $2.33. It's PE Ratio (TTM) ratio for today is 14.70.

Phibro Animal Health's EPS without NRI for the three months ended in Mar. 2026 was $0.76. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was $2.93. It's PE Ratio without NRI ratio for today is 11.69.


Be Aware

Assumption: Companies usually do not report maintenance capital expenditures and growth capital expenditures separately. Here we use estimated numbers and average them over 5 years. The method to estimate maintenance capital expenditures can be found in above part 4.

Note: GuruFocus' Change In Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And it includes non-current parts of assets and liabilities.


Phibro Animal Health Owner Earnings per Share (TTM) Related Terms


Phibro Animal Health Owner Earnings per Share (TTM) Historical Data

* Premium members only.

The historical data trend for Phibro Animal Health's Owner Earnings per Share (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phibro Animal Health Owner Earnings per Share (TTM) Chart

Phibro Animal Health Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Owner Earnings per Share (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.78 0.30 -0.20 0.80 0.89

Phibro Animal Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Owner Earnings per Share (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.90 0.89 0.72 1.43 0.71

PAHC vs PRGO, HROW, XERS: Owner Earnings per Share (TTM) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Phibro Animal Health's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Phibro Animal Health Price-to-Owner-Earnings vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Phibro Animal Health's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Phibro Animal Health's Price-to-Owner-Earnings falls into.


PAHC
75GF Score
Phibro Animal Health Corp PAHC
Owner Earnings per Share (TTM) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Phibro Animal Health Owner Earnings per Share (TTM) Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

To make it simple, then you will have:

Owner Earnings per Share (TTM) = (Net Income + Depreciation, Depletion and Amortization + Change In Deferred Tax - 5Y Average of Maintenance Capital Expenditure + Change In Working Capital) / Shares Outstanding (Diluted Average)

Phibro Animal Health's Owner Earnings per Share (TTM) Calculation:

TTM / Last Quarter Average of Last 20 Quarters
Net Income 95
Depreciation, Depletion and Amortization 51
Change In Deferred Tax 18
5Y Average of Maintenance Capital Expenditure 35
Change In Working Capital -100
Shares Outstanding (Diluted Average) 41

1. Start with "Net Income" from income statement. Phibro Animal Health's Net Income for the trailing twelve months (TTM) ended in Mar. 2026 was $95 Mil.

2. "Depreciation, Depletion and Amortization" is from cashflow statement. Phibro Animal Health's Depreciation, Depletion and Amortization for the trailing twelve months (TTM) ended in Mar. 2026 was $51 Mil. This needs to be added back because company does not actually need to pay cash for it. It is a non-cash item.

3. Other non-cash charges usually include "Stock Based Compensation" and "Change In Deferred Tax":
However, to be conservative, GuruFocus will not add Stock Based Compensation back to net income. Phibro Animal Health's Change In Deferred Tax for the trailing twelve months (TTM) ended in Mar. 2026 was $18 Mil.

4. Average maintenance capital expenditure over a business/industry cycle: 5-Year Average Maintenance Capital Expenditure = $35 Mil

It is usually best to take a long-term average of maintenance capital expenditure. Ideally this would be as long as 10 years and include at least one economic downturn. However, since many companies do not have as long as 10-year history, here GuruFocus uses the latest 5 years data to do the calculation. To smooth out unusual years but reflect recent developments, we take an average of the 5 year maintenance capital expenditure.

The following shows how to get maintenance capital expenditure.

First, calculate the revenue change regarding to the previous quarter. If the revenue decreased from the previous quarter, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
Second, if the revenue increased from the previous quarter, then calculate the percentage of Net PPE as of corresponding Revenue.
Growth Capital Expenditure = Percentage of Property, Plant and Equipment as of corresponding Revenue * Revenue Increase
Third, calculate Capital Expenditure (positive) - Growth Capital Expenditure.
If [Capital Expenditure (positive) - Growth Capital Expenditure] was negative, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
If [Capital Expenditure (positive) - Growth Capital Expenditure] was positive, then the Maintenance Capital Expenditure = Capital Expenditure (positive) - Growth Capital Expenditure.
Fourth, get the average of the 5 years maintenance capital expenditure.

Phibro Animal Health's 5-Year Average Maintenance Capital Expenditure = $35 Mil

5. "Change In Working Capital" is from cashflow statement. Phibro Animal Health's Change In Working Capital for the trailing twelve months (TTM) ended in Mar. 2026 was $-100 Mil.
Note: GuruFocus' Change in Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And sometimes it includes non-current parts of assets and liabilities.

6. Phibro Animal Health's Shares Outstanding (Diluted Average) for the months ended in Mar. 2026 was 41.037 Mil.

Phibro Animal Health's Onwer Earnings Per Share for Mar. 2026 is calculated as:

Owner Earnings per Share (TTM)
=( Net Income+Depreciation, Depletion and Amortization+Change In Deferred Tax
=( 95.234 +50.58+18.03
-5Y Avg of Maintenance CAPEX+Change In Working Capital )/Shares Outstanding (Diluted Average)
-34.996602379288+-99.589)/41.037
=0.71

Price-to-Owner-Earnings=Current Price/Owner Earnings per Share (TTM)
=34.26/0.71
=48.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Owner Earnings per Share (TTM) of 0.71 mean?
Phibro Animal Health (PAHC) has a Owner Earnings per Share (TTM) of 0.71 as of Mar. 2026. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on Phibro Animal Health. This is 98% below median its historical median of 31.59. Over the past decade, Phibro Animal Health's Owner Earnings per Share (TTM) has ranged from 12.54 to 436.78. According to the industry distribution chart, Phibro Animal Health ranks #356 out of 470 companies in the Drug Manufacturers industry, placing it in the top 75.7%.
Is Phibro Animal Health's Owner Earnings per Share (TTM) too high?
Phibro Animal Health's current Owner Earnings per Share (TTM) of 0.71 is 98% below median its 10-year median of 31.59. Over the past 10 years, this metric has ranged from a low of 12.54 to a high of 436.78. The Drug Manufacturers industry median Owner Earnings per Share (TTM) is 23.33. Phibro Animal Health's value of 0.71 is 97% below this industry median. Based on the distribution chart, Phibro Animal Health ranks #356 out of 470 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Phibro Animal Health has a GF Scoreâ„¢ of 75/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Phibro Animal Health's Owner Earnings per Share (TTM) compare to PRGO and HROW?
According to the Drug Manufacturers industry distribution chart, Phibro Animal Health ranks #356 out of 470 companies for Owner Earnings per Share (TTM). This places Phibro Animal Health in the lower half of its industry. The industry median Owner Earnings per Share (TTM) is 23.33. Phibro Animal Health's value of 0.71 is 97% below this benchmark. Historically, Phibro Animal Health's own Owner Earnings per Share (TTM) has ranged from 12.54 to 436.78 over the past decade. While the company's 10-year median is 31.59 vs. the industry median of 23.33, Phibro Animal Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Owner Earnings per Share (TTM) for a Drug Manufacturers company?
The median Owner Earnings per Share (TTM) among Drug Manufacturers companies is 23.33, based on 470 companies in the industry. Companies in the top quartile (top 25%) have a Owner Earnings per Share (TTM) significantly above this median, while those in the bottom quartile fall well below. However, Owner Earnings per Share (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Phibro Animal Health's current Owner Earnings per Share (TTM) of 0.71 is 97% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Owner Earnings per Share (TTM) mean?
A high Owner Earnings per Share (TTM) can signal that a stock is expensive relative to its fundamentals. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on Phibro Animal Health. For the Drug Manufacturers industry, the median Owner Earnings per Share (TTM) is 23.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phibro Animal Health's current Owner Earnings per Share (TTM) is 0.71, which is 98% below median its own 10-year median of 31.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phibro Animal Health stock overvalued right now?
Based on GuruFocus' analysis, Phibro Animal Health (PAHC) is currently considered Modestly Overvalued. The stock's GF Value™ is $29.54, compared to a current price of $34.26 — trading 16% above its estimated fair value. The current Owner Earnings per Share (TTM) is 0.71, which is 98% below median its 10-year median of 31.59 and 97% below the Drug Manufacturers industry median of 23.33. Phibro Animal Health's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Owner Earnings per Share (TTM) calculated?
Owner Earnings per Share (TTM) is calculated from a company's financial statements. For Phibro Animal Health (PAHC), the current Owner Earnings per Share (TTM) is 0.71 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Phibro Animal Health (PAHC) Overvalued in 2026?

Based on GuruFocus' analysis, Phibro Animal Health stock appears to be overvalued. The current stock price of $34.26 is trading 16% above its estimated GF Value™ of $29.54. GuruFocus considers Phibro Animal Health to be Modestly Overvalued.

Key valuation signals for PAHC:

  • Owner Earnings per Share (TTM): 0.71 (98% below median its 10-year median of 31.59)
  • GF Value™: $29.54 vs. price of $34.26 (16% above fair value)
  • GF Score™: 75/100 with 4 warning signs
  • Industry Position: 97% below the Drug Manufacturers median (#356 of 470)

No single metric tells the full story. See the PAHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Phibro Animal Health Business Description

Other Exchanges PB8:Germany
Address 300 Frank W. Burr Boulevard, Suite 21, 3rd Floor, Glenpointe Centre East, Teaneck, NJ, USA, 07666-6712
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
75GF Score

Get the complete analysis for PAHC

Owner Earnings per Share (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$34.26
Price
$29.54
GF Value